The emergence of SARS-CoV-2 variants harboring mutations in the spike (S) protein has
raised concern about potential immune escape. Here, we studied humoral and cellular …

The severe acute respiratory distress syndrome coronavirus 2 (SARS-CoV-2) Omicron
variant is spreading rapidly, even in vaccinated individuals, raising concerns about immune …

The world is entering a new era of the COVID-19 pandemic in which there is an increasing
call for reliable antibody testing. To support decision making on the deployment of serology …

Background An urgent need exists to improve the suboptimal COVID-19 vaccine response
in kidney transplant recipients (KTRs). We aimed to compare three alternative strategies with …

In July 2022, the ongoing monkeypox (MPX) outbreak was declared a public health emergency
of international concern. Modified vaccinia Ankara—Bavarian Nordic (MVA-BN, also …

Background Vaccines can be less immunogenic in people living with HIV (PLWH), but for
SARS-CoV-2 vaccinations this is unknown. In this study we set out to investigate, for the …

Background SARS-CoV-2 vaccines are highly effective at preventing COVID-19-related
morbidity and mortality. As no vaccine is 100% effective, breakthrough infections are expected to …

Background Bivalent mRNA-based COVID-19 vaccines encoding the ancestral and omicron
spike (S) protein were developed as a countermeasure against antigenically distinct SARS-…

Objectives The potential benefit of convalescent plasma (CP) therapy for coronavirus disease
2019 (COVID-19) is highest when administered early after symptom onset. Our objective …

Background The aim of this randomized, controlled trial is to determine whether antisevere
acute respiratory syndrome coronavirus 2 hyperimmune globulin (COVIG) protects against …